Skip to main content
SpringerLink
Log in
Book cover

Textbook of Palliative Care pp 1–21Cite as

Skin Symptoms

  • Living reference work entry
  • First Online:

  • 388 Accesses

Abstract

The skin is the largest organ of the body. In life-limiting illnesses, there are a number of important skin manifestations that may cause considerable suffering to patients and, indirectly, to their family and carers. They include pruritus, pathological sweating, skin failure, and malignant cutaneous wounds. This chapter will review the pathophysiological mechanisms, epidemiology, assessment, and management of these manifestations. Each section will be accompanied by a set of evidence-based management recommendations for clinicians.

This is a preview of subscription content, log in via an institution.

References

  • Alexander S. Malignant fungating wounds: epidemiology, aetiology, presentation and assessment. J Wound Care. 2009;18(7):273–80.

    Article  CAS  PubMed  Google Scholar 

  • Aperis G, Paliouras C, Zervos A, et al. The use of pregabalin in the treatment of uraemic pruritus in haemodialysis patients. J Renal Care. 2010;36(4):180–5.

    Article  Google Scholar 

  • Aramwit P, Keongamaroon O, Siritientong T, et al. Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study. BMC Nephrol. 2012;13:119.

    Article  PubMed  PubMed Central  Google Scholar 

  • Australian Wound Management Association. Pan Pacific clinical practice guideline for the prevention and management of pressure injury. West Leederville: Cambridge Media Osborne Park; 2012.

    Google Scholar 

  • Berg CL, Gollan JL. Primary biliary cirrhosis: new therapeutic directions. Scand J Gastroenterol Suppl. 1992;192:43–9.

    Article  CAS  PubMed  Google Scholar 

  • Bergasa NV. Pruritus of cholestasis. In: Carstens E, Akiyama T, editors. Itch – mechanisms and treatment. Boca Raton: CRC Press; 2014. p. 65.

    Google Scholar 

  • Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology. 1992;102(2):544–9.

    Article  CAS  PubMed  Google Scholar 

  • Bergasa NV, Liau S, Homel P, et al. Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis. Liver. 2002;22(2):107–13.

    Article  CAS  PubMed  Google Scholar 

  • Bergasa NV, McGee M, Ginsburg IH, Engler D. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology. 2006;44:1317–23.

    Article  CAS  PubMed  Google Scholar 

  • Beuers U, Kremer AE, Bolier R, et al. Pruritus in cholestasis – facts and fiction. Hepatology. 2014;60(1):399–407.

    Article  CAS  PubMed  Google Scholar 

  • Booken N, Heck M, Nicolay JP. Oral aprepitant in the therapy if refractory pruritus in erythrodermic cutaneous T-cell lymphoma. Brit J Dermatol. 2011;164:665–83.

    CAS  Google Scholar 

  • Breneman DL, Cardone JS, Blumsack RF, et al. Topical capsaicin for treatment of haemodialysis-related pruritus. J Am Acad Dermatol. 1992;26:91–4.

    Article  CAS  PubMed  Google Scholar 

  • Brennan F. The pathophysiology of pruritus – a review for clinicians. Prog Pall Care. 2016;24(3):133–46.

    Article  Google Scholar 

  • Brown G. Long term outcomes of full thickness pressure areas: healing and mortality. Ostomy Wound Manage. 2003;9(10):42–50.

    Google Scholar 

  • Calder K, Bruera E. Thalidomide for night sweats in patients with advanced cancer. Palliat Med. 2000;14:77–8.

    Article  CAS  PubMed  Google Scholar 

  • Chen YC, Chiu W-T, Wu M-S. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus. Am J Kidney Dis. 2006;48:69–76.

    Article  CAS  PubMed  Google Scholar 

  • Combs SA, Teixeira JP, Germain MJ. Pruritus in kidney disease. Semin Nephrol. 2015;35(40):383–91.

    Article  PubMed  PubMed Central  Google Scholar 

  • Datna DV, Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology. 1966;50(3):323–32.

    Google Scholar 

  • Dawn AG, Yosipovitch G. Butorphanol for the treatment of intractable pruritus. J Am Acad Dermatol. 2006;54:527–31.

    Article  PubMed  Google Scholar 

  • Decock S, Roelandts R, Steenbergen WV, et al. Cholestasis-induced pruritus treated with ultraviolet-B phototherapy: an observational case series. J Hepatol. 2012;57(3):637–41.

    Article  CAS  PubMed  Google Scholar 

  • Demierre M-F, Taverna J. Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma. J Am Acad Dermatol. 2006;55(3):543–4.

    Article  PubMed  Google Scholar 

  • Dowsett C. Malignant fungating wounds: assessment and management. Br J Community Nurs. 2002;7(8):394–400.

    Article  PubMed  Google Scholar 

  • Duque MI, Yosipovitch G, Fleisher AB, et al. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol. 2005;52:519–21.

    Article  PubMed  Google Scholar 

  • Duval A, Dubertret L. Aprepitant as an antipruritic agent ? N Engl J Med. 2009;361(14):1415–6.

    Article  CAS  PubMed  Google Scholar 

  • Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampacin. Results of a double-blind, crossover, randomized trial. Gastroenterology. 1988;94:488–93.

    Article  CAS  PubMed  Google Scholar 

  • Gilchrest BA, Rowe JW, Brown RS, et al. Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med. 1977;297:136–8.

    Article  CAS  PubMed  Google Scholar 

  • Gilchrest BA, Rowe JW, Brown RS, et al. Ultraviolet phototherapy of uremic pruritus. Ann Intern Med. 1979;91:17–21.

    Article  CAS  PubMed  Google Scholar 

  • Gingold AR, Bergasa NV. The cannabinoid agonist WIN 55, 212-2 increases nocioception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis. Life Sci. 2003;73(2):2741–7.

    Article  CAS  PubMed  Google Scholar 

  • Goode PS, Allman RM. The prevention and management of pressure ulcers. Med Clin North Am. 1989;73(6):1511–24.

    Article  CAS  PubMed  Google Scholar 

  • Gonclaves F. Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin’s disease. Am J Hosp Palliat Care. 2010;27(7):486–7.

    Article  Google Scholar 

  • Grocott PR. Palliative management of Fungating malignant wounds. Eur J Cancer. 1995;31:S308.

    Article  Google Scholar 

  • Haffenreffer S. De pruritu, Nosodochium in Quo Cutis. In: Eique Adhaerentium Partium, Affectus Omnes, Singulari Methodo, Et Cognoscendi Et Curandi Fidelissime Traduntur. Ulm: Kuhnen Balthasar; 1660. p. 98–102.

    Google Scholar 

  • Heathcote EJ. Is rifampicin a safe and effective treatment for pruritus caused by chronic cholestasis? Nat Clin Pract Gastroenterol Heapatol. 2007;494:200–1.

    Article  CAS  Google Scholar 

  • Hobbs RN. Walk with me – physicians’ and patients’ stories and their role in palliative care education. J Palliat Care. 1993;9(2):41–6.

    CAS  PubMed  Google Scholar 

  • Irvine B. Developments in palliative nursing in and out of the hospital settings. Br J Nurs. 2016;2(4):218–24.

    Article  Google Scholar 

  • Karadag E, Kilic SP, Karatay G, et al. Effect of baby oil on pruritus, sleep quality, and quality of life in hemodialysis patients: pretest-post-test model with control groups. Jpn J Nurs Sci. 2014;11:180–9.

    Article  PubMed  Google Scholar 

  • Kilic A, Gul U, Soylu S. Skin findings in internal malignant diseases. Int J Dermatol. 2007;46:1055–60.

    Article  PubMed  Google Scholar 

  • Kim KH, Lee MS, Choi SM. Acupuncture for treating uremic pruritus in patients with end-stage renal disease; a systematic review. J Pain Symptom Manag. 2010;40:117–25.

    Article  Google Scholar 

  • Ko MJ, Yang JY, HY W, et al. Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial. Brit J Dermatol. 2011;165:633–9.

    Article  Google Scholar 

  • Kremer AE, Beuers U, Oude-Elferink RP, et al. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163–82.

    Article  CAS  PubMed  Google Scholar 

  • Kremer AE, Martens JJ, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 2010;139:1008–18.

    Article  CAS  PubMed  Google Scholar 

  • Kremer AE, van Dijk R, Leckie P, et al. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology. 2012;56:1391–400.

    Article  CAS  PubMed  Google Scholar 

  • Kremer AE, Bolier R, van Dijk R, et al. Advances in pathogenesis and management of pruritus in cholestasis. Dig Dis. 2014;32:637–45.

    Article  PubMed  Google Scholar 

  • Kumagai H, Ebata T, Takamori K, et al. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo controlled study. Nephrol Dial Transplant. 2010;25(4):1251–7.

    Article  CAS  PubMed  Google Scholar 

  • Kumagai H, Ebata T, Takamori K, et al. Efficacy and safety of a novel k-agonist for managing intractable pruritus in dialysis patients. Am J Nephrol. 2012;36:175–83.

    Article  CAS  PubMed  Google Scholar 

  • Kuypers DR, Claes K, Evenepoel P, et al. A prospective proof of concept study of the efficacy of tacrolimus ointment on uremic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant. 2004;19:1895–901.

    Article  CAS  PubMed  Google Scholar 

  • Langemo DK, Brown G. Skin fails too: acute, chronic and end-stage skin failure. Adv Skin Wound Care. 2006;19(4):206–11.

    Article  PubMed  Google Scholar 

  • La Puma J. The ethics of pressure ulcers. Adv Skin Wound Care. 1991;4(2):43–5.

    Google Scholar 

  • Lau T, Leung S, Lau W. Gabapentin for uremic pruritus in hemodialysis patients: a qualitative systematic review. Can J Kidney Health Dis. 2016;3:1–14.

    Article  Google Scholar 

  • Legroux-Crespel E, Cledes J, Misery L. A comparative study on the effects of naltrexone and loratadine on uremic pruritus. Dermatology. 2004;208:326–30.

    Article  CAS  PubMed  Google Scholar 

  • Lin TC, Lai YH, Guo SE, et al. Baby oil therapy for uremic pruritus in hemodialysis patients. J Clin Nurs. 2012;21:139–48.

    Article  CAS  PubMed  Google Scholar 

  • Lo S, Hu W, Hayter M, Chang S, Hsu M, Wu L. Experiences of living with a malignant fungating wound: a qualitative study. J Clin Nurs. 2008;17(20):2699–708.

    Article  PubMed  Google Scholar 

  • Maida V. Nabilone for the treatment of paraneoplastic night sweats: a report of four cases. J Palliat Med. 2008;11(6):929–34.

    Article  PubMed  Google Scholar 

  • Maida V, Ennis M, Kuziemsky C, Trozzolo L. Symptoms associated with malignant wounds: a prospective case series. J Pain Symptom Manag. 2009;37(2):206–11.

    Article  Google Scholar 

  • Makhlough A, Ala S, Haj-Heydari Z, et al. Topical capsaicin therapy for uremic pruritus in patients on hemodialysis. Iran J Kidney Dis. 2010;4:137–40.

    PubMed  Google Scholar 

  • Mathur VS, Lindberg J, Germain M, et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5:1410–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mayo MM, Handem I, Saldana S, et al. Sertraline as a first line treatment for cholestatic pruritus. Hepatology. 2007;45:666–74.

    Article  CAS  PubMed  Google Scholar 

  • McCormick PA, Scott F, Epstein O, et al. Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study. J Hepatol. 1994;21:496–9.

    Article  CAS  PubMed  Google Scholar 

  • McMurray V. Managing patients with fungating malignant wounds. Nurs Times. 2003;99(13):55–7.

    PubMed  Google Scholar 

  • Mettang T. Pruritus in kidney disease. In: Carstens E, Akiyama T, editors. Itch – mechanisms and treatment. Boca Raton: CRC Press; 2014.

    Google Scholar 

  • Morton CA, Lafferty M, Lau C, et al. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant. 1996;11:2031–6.

    Article  CAS  PubMed  Google Scholar 

  • Murphy M, Reaich D, Pai P, et al. A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch. Brit J Dermatol. 2003;148(2):314–7.

    Article  CAS  Google Scholar 

  • Murtagh FEM, Addington-Hall JM, Edmonds PM, et al. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney diseases managed without dialysis. J Palliat Med. 2007;10(6):1266–76.

    Article  PubMed  Google Scholar 

  • Nasrollahi A, Miladipour A, Ghanei E, et al. Montelukast for treatment of refractory pruritus in patients on hemodialysis. Iran J Kidney Dis. 2007;1(2):73–7.

    PubMed  Google Scholar 

  • National Pressure Ulcer Advisory Panel. NPUAP Pressure Injury Stages. United States of America: National Pressure Ulcer Advisory Panel; 2016 (Cited 2016 October 10). Available from: http://www.npuap.org/resources/educational-and-clinical-resources/npuap-pressure-injury-stages/

  • Naylor W. Assessment and management of pain in fungating wounds. Br J Nurs. 2001;10(Sup5):S33–56.

    Article  CAS  PubMed  Google Scholar 

  • Neff GW, O’Brien CB, Reddy KR, et al. Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. Am J Gastroenterol. 2002;97(8):2117–9.

    Article  PubMed  Google Scholar 

  • Nieto-Posadas A, Picazo-Juaraez G, Llorente I, et al. Lysophosphatidic acid directly activates TRPV1 through a C-binding site. Nat Chem Biol. 2012;8:78–85.

    Article  CAS  Google Scholar 

  • Noble H, Meyer J, Bridge J, et al. Exploring symptoms in patients managed without dialysis: a qualitative research study. J Ren Care. 2010;36(1):9–15.

    Article  PubMed  Google Scholar 

  • Papiou ADP, Emerson NM, Patel TS, et al. Voxel-based morphometry and arterial spin labelling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease. J Neurophysiol. 2014;112:1729–38.

    Article  Google Scholar 

  • Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis. 2007;50:11–20.

    Article  PubMed  Google Scholar 

  • Pauli-Magnus C, Mikus G, Alscher DM, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol. 2000;11:514–9.

    CAS  PubMed  Google Scholar 

  • Peer G, Kivity S, Agami O, et al. Randomised crossover trial of naltrexone in uremic pruritus. Lancet. 1996;348:1552–4.

    Article  CAS  PubMed  Google Scholar 

  • Pisoni RL, Wikstrom B, Elder SJ, et al. Pruritus in haemodialysis patients: international results from Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21:3495–505.

    Article  PubMed  Google Scholar 

  • Probst S, Arber A, Faithful S. Malignant fungating wounds – the meaning of living in an unbounded body. Eur J Oncol Nurs. 2013:38–45.

    Google Scholar 

  • Rayner H, Baharani J, Smith S, et al. Uraemic pruritus: relief of itching by gabapentin and pregabalin. Nephron Clin Pract. 2012;122:75–9.

    Article  CAS  PubMed  Google Scholar 

  • Razeghi E, Ejkandari D, Ganji M, et al. Gabapentin and uremic pruritus in hemodialysis patients. Ren Fail. 2009;31(2):85–90.

    Article  CAS  PubMed  Google Scholar 

  • Rowe B, Yosipovitch G. Paraneoplastic itch management. In: Szepietowski JC, Weisshaar E, editors. Itch – Management in Clinical Practice. Basel: Karger; 2016. p. 149–54.

    Chapter  Google Scholar 

  • Rubenstein M, Duvic M. Cutaneous manifestations of Hodgkin’s Disease. Int J Dermatol. 2006;45:252–6.

    Article  Google Scholar 

  • Schank JE. Kennedy terminal ulcer: the “ah-ha!” moment. Ostomy Wound Manage. 2009;55(9):40–44.

    PubMed  Google Scholar 

  • Seaman S. Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs. 2006;22(3):185–93.

    Article  PubMed  Google Scholar 

  • Shakiba M, Sanadgol H, Azmoude HR et al. Effect of sertraline on uremic pruritus improvement in ESRD patients. Int J Nephrol. 2012:363901; 1–5.

    Google Scholar 

  • Shavit L, Grenader T, Lifschitz M, et al. Use of pregabalin in the management of chronic uremic pruritus. J Pain Symptom Manag. 2013;45(4):776–81.

    Article  CAS  Google Scholar 

  • Sibbald RG, Krasner DL, Lutz J. SCALE: skin changes at life’s end final consensus statement. Adv Skin Wound Care. 2009;23(5):225–36.

    Article  Google Scholar 

  • Silva SRB, Viana PCF, Lugon NV, et al. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron. 1994;67:270–3.

    Article  CAS  PubMed  Google Scholar 

  • Smith CJ, Johnson JM. Responses to hyperthermia. Optimizing heat dissipation by convection and evaporation: neural control of skin blood flow and sweating in humans. Auton Neurosci. 2016;196:25–36.

    Article  PubMed  Google Scholar 

  • Solak Y, Biyik Z, Atalay H, et al. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study. Nephrology. 2012;17:71–717.

    Article  CAS  Google Scholar 

  • Stander S, Luger TA. NK-I antagonists and itch. In: Cowan A, Yosipovitch A, editors. Pharmacology of itch. Heidelberg: Springer; 2015.

    Google Scholar 

  • Swain MG. Pruritus and lethargy in the primary biliary cirrhosis patient. In: Neuberger J, editor. Primary biliary cirrhosis. Eastbourne: West End Studios; 1999. p. 75–81.

    Google Scholar 

  • Ta Y, Patel TS, Camacho F, et al. A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients. J Dermatol Treat. 2009;20:76–81.

    Article  CAS  Google Scholar 

  • Tan JK, Haberman HF, Coldman AJ. Identifying effective treatments for uremic pruritus. J Am Acad Dermatol. 1991;25(5 Pt 1):811–8.

    Article  CAS  PubMed  Google Scholar 

  • Tandon P, Rowe BH, Vandermeer B, et al. The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampicin in the treatment of cholestasis-associated pruritus. Am J Gastroenterol. 2007;102(7):1528–36.

    Article  CAS  PubMed  Google Scholar 

  • Tarng DC, Cho YL, Liu HN, et al. Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron. 1996;72:617–22.

    Article  CAS  PubMed  Google Scholar 

  • Terg R, Coronel E, Sorda J, et al. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol. 2002;37(60):717–22.

    Article  CAS  PubMed  Google Scholar 

  • Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. Br Med J. 1988;297(6662):1501–4.

    Article  CAS  Google Scholar 

  • To T, Clark K, Lam L, et al. The role of ondansetron in the management of cholestatic or uremic pruritus – a systematic review. J Pain Symptom Manag. 2012;44:725–30.

    Article  CAS  Google Scholar 

  • Trivedi M, Bergasa NV. Serum concentrations of substance P in cholestasis. Ann Hepatol. 2010;99(2):177–80.

    Google Scholar 

  • Twycross R, Wilcock A, Howard P, editors. Palliative Care Formulary. 5th ed. Nottingham: Palliative Care Drugs.com; 2014.

    Google Scholar 

  • Villafranca JJA, Siles M, Casanova M, et al. Paraneoplastic pruritus presenting with Hodgkin’s lymphoma; a case report. J Med Case Reports. 2014;8:300.

    Article  Google Scholar 

  • Villamil AG, Bandi JC, Galdame O, et al. Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases. Am J Med. 2005;118(10):1160–3.

    Article  CAS  PubMed  Google Scholar 

  • Waran E. Doctor, I am sweating on just one side of my body: unilateral hyperhidrosis associated with mesothelioma. Clin Case Rep. 2016;4(5):533–4.

    Article  PubMed  PubMed Central  Google Scholar 

  • Weisshaar E, Dunkler N, Rohl FW, et al. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients. Exp Dermatol. 2004;24:298–304.

    Article  Google Scholar 

  • Weisshaar E, Szepietowski JC, Drashow U, et al. European guideline on chronic pruritus. Acta Derm Venereol. 2012;92:563–81.

    Article  PubMed  Google Scholar 

  • Weisshaar E, Weiss M, Mettang T, Yosipovitch G, Zylicz Z. Paraneoplastic itch: an expert position statement from the Special Interest Group (SIG) of the International Forum on the Study of Itch (IFSI). Acta Derm Venerol. 2015;95:261–5.

    Article  PubMed  Google Scholar 

  • Wikstrom B, Gellert R, Ladefoged SD, et al. Kappa-opioid system in uremic pruritus : multicentre, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol. 2005;16:3742–7.

    Article  PubMed  CAS  Google Scholar 

  • Wilson V. Assessment and management of fungating wounds: a review. Br J Community Nurs. 2005;10(Sup1):S28–34.

    Article  PubMed  Google Scholar 

  • Witkowski JA, Parrish LC. The decubitus ulcer. Skin failure and destructive behaviour. Int J Dermatol. 2000;39(12):894–6.

    Article  CAS  PubMed  Google Scholar 

  • Wolfhagen FHJ, Sternieri E, Hop WCJ, et al. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology. 1997;113(4):1264–9.

    Article  CAS  PubMed  Google Scholar 

  • Worley CA. The permissible pressure ulcer. Dermatol Nurs. 2007;19:384–5.

    PubMed  Google Scholar 

  • Yoshimoto-Furuie K, Yoshimoto K, Tanaka T, et al. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms on hemodialysis patients. Nephron. 1999;81:151–9.

    Article  CAS  PubMed  Google Scholar 

  • Yosipovitch G, Bernhard JD. Clinical practice – chronic pruritus. New Engl J Med. 2013;368:1625–34.

    Article  CAS  PubMed  Google Scholar 

  • Young TA, Patel TS, Camacho F, et al. A pramoxine-based anti-itch lotion is more effective than a control for the treatment of uremic pruritus in adult hemodialysis patients. J Dermatol Treat. 2009;20(2):76–81.

    Article  CAS  Google Scholar 

  • Yue J, Jiao S, Xiao Y, et al. Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study. Int Urol Nephrol. 2015;47(1):161–7.

    Article  CAS  PubMed  Google Scholar 

  • Zylicz Z, Krajnik M. Flushing and sweating in an advanced breast cancer patient relieved by Olanzapine. J Pain Sympt Manage. 2003;25(6):494–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Palliative Care Physician, St George and Calvary Hospitals, Sydney, Australia

    Frank Brennan

  2. Wound Management Clinical Nurse Consultant, St George Hospital, Sydney, Australia

    Mathew Dutton

  3. Palliative Care Clinical Nurse Consultant, St George Hospital, Sydney, Australia

    Linda Magann

Authors
  1. Frank Brennan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mathew Dutton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Linda Magann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. HammondCare Learning and Research Centre, Greenwich Hospital, Greenwich, New South Wales, Australia

    Roderick Duncan MacLeod

  2. Vrije Universiteit Brussel, VUB-UGent End-of-Life Care Research Grou Vrije Universiteit Brussel, Brussels, Belgium

    Lieve van den Block

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Brennan, F., Dutton, M., Magann, L. (2018). Skin Symptoms. In: MacLeod, R., van den Block, L. (eds) Textbook of Palliative Care. Springer, Cham. https://doi.org/10.1007/978-3-319-31738-0_18-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31738-0_18-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31738-0

  • Online ISBN: 978-3-319-31738-0

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Search

Navigation